| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US6306431 | GALEN SPECIALTY | Apparatus for heating to a desired temperature for improved administration of pharmaceutically active compounds |
Jul, 2015
(8 years ago) | |
| US5658583 | GALEN SPECIALTY | Apparatus and methods for improved noninvasive dermal administration of pharmaceuticals |
Jul, 2015
(8 years ago) | |
| US6780426 | GALEN SPECIALTY | Method and apparatus for improved heat controlled administration of pharmaceuticals |
Jul, 2015
(8 years ago) | |
| US6546281 | GALEN SPECIALTY | Integrated apparatus for controlled heat aided dermal drug delivery |
Jul, 2015
(8 years ago) | |
| US5919479 | GALEN SPECIALTY | Noninvasive dermal anesthetics |
Jul, 2015
(8 years ago) | |
| US6465006 | GALEN SPECIALTY | Method for facilitating absorption of pharmaceutically active compounds |
Jul, 2015
(8 years ago) | |
| US6465709 | GALEN SPECIALTY | Exothermic bandage |
Jul, 2020
(3 years ago) | |
Synera is owned by Galen Specialty.
Synera contains Lidocaine; Tetracaine.
Synera has a total of 7 drug patents out of which 7 drug patents have expired.
Expired drug patents of Synera are:
- US6306431
- US5658583
- US6780426
- US6546281
- US5919479
- US6465006
- US6465709
Synera was authorised for market use on 23 June, 2005.
Synera is available in patch;topical dosage forms.
The generics of Synera are possible to be released after 07 July, 2020.
Drugs and Companies using LIDOCAINE; TETRACAINE ingredient
Market Authorisation Date: 23 June, 2005
Treatment: NA
Dosage: PATCH;TOPICAL
More Information on Dosage
SYNERA family patents
